Cidara Therapeutics, Inc.
Cidara Therapeutics, Inc.（CDTX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
cdtx · 股价预测 · 11 位分析师（近3月）· FMP · 更新于 2026年2月6日
分析师评级与共识
基于过去 3 个月内 11 位华尔街分析师
Buy
11 位分析师
共识
评级分布
12 个月目标价
High
$222
Consensus
$178
-19.6% upside
Low
$150
Median: $170 · Last Close: $221.38
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$177.88
-19.6% upside
High Target
$221.5
0.1%
Low Target
$150
-32.2%
Current Price
$221.38
as of today
Based on analyst price targets, the CDTX stock price prediction for the next 12 months ranges from $150 to $221.5. The consensus CDTX price forecast of $177.88 implies -19.6% upside from the current price of $221.38.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $221.08 | ↓ 0.14% |
1-day model range: $221.01–$221.14. Peak: $221.14 (-0.14%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CDTX · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-11-18 | Guggenheim | Downgrade ↓ | Buy→Neutral |
| 2025-11-14 | Needham | Downgrade ↓ | Buy→Hold |
| 2025-11-14 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2025-11-07 | Needham | Maintains | Buy→Buy |
| 2025-11-07 | RBC Capital | Maintains | Outperform→Outperform |
| 2025-10-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-09 | WBB Securities | Maintains | Strong Buy→Strong Buy |
| 2025-10-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-03 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2025-09-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Cidara Therapeutics, Inc. (CDTX) stock. Of the recent 73 rating actions, 6 were upgrades and 6 were downgrades. 11 analysts currently cover CDTX.
分析师推荐趋势
CDTX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 6 to 2 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$54M
↑ 357.9% YoY
Revenue Next Year
$8M
↓ 84.3% YoY
EPS This Year
$-7.63
EPS Next Year
$-6.24
↓ 18.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast CDTX EPS of $-7.63 for the current fiscal year, based on estimates from 4 analysts. The CDTX revenue forecast is $54M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CDTX 股价预测由两类独立数据源支撑：来自 11 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CDTX 的共识目标价为 $177.88（-19.6% 上行空间），分析师共识为 Buy。
CDTX 的短期预测（明日）为 $221.08（-0.14%）。
Cidara Therapeutics, Inc. 在 NASDAQ 上市，代码 CDTX。CDTX 在 2027 年的整体展望偏积极，在覆盖分析师中约 73% 对应 Buy 共识。
常见问题
CDTX 预测 · 8 个问题根据 11 位华尔街分析师，CDTX 的 12 个月平均目标价为 $177.88，最高 $221.50、最低 $150.00。若有图表，中位目标价可在上方查看。相对当前价 $221.38，隐含约 -19.6% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.